pd-0332991
Showing 1 - 9 of 9
Advanced Hepatocellular Carcinoma, HCC, Liver Cancer Trial in Philadelphia (PD-0332991)
Active, not recruiting
- Advanced Hepatocellular Carcinoma
- +2 more
- PD-0332991
-
Philadelphia, PennsylvaniaThomas Jefferson University
Sep 21, 2021
Adult Solid Tumor, Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum Trial in Philadelphia (PD-0332991)
Completed
- Adult Solid Tumor
- +38 more
- PD-0332991
-
Philadelphia, PennsylvaniaAbramson Cancer Center of The University of Pennsylvania
Feb 18, 2021
Tumors, Breast Tumors Trial in Japan (PD-0332991, letrozole)
Completed
- Neoplasms
- Breast Neoplasms
- PD-0332991
- letrozole
-
Nagoya, Aichi, Japan
- +15 more
Oct 28, 2020
Advanced Solid Tumor Malignancies Trial in Washington (PD-0332991, 5-FU, Oxaliplatin)
Unknown status
- Advanced Solid Tumor Malignancies
- PD-0332991
- +2 more
-
Washington, District of ColumbiaGeorgetown Lombardi Comprehensive Cancer Center
Mar 2, 2020
Breast Tumors Trial in Worldwide (PD-0332991, Letrozole, Placebo)
Active, not recruiting
- Breast Neoplasms
- PD-0332991
- +2 more
-
Bellflower, California
- +304 more
Dec 6, 2022
Tumors, Lymphoma, Non-Hodgkin Trial in Detroit, New York, Philadelphia (PD-0332991)
Completed
- Neoplasms
- Lymphoma, Non-Hodgkin
- PD-0332991
-
Detroit, Michigan
- +3 more
Dec 3, 2015
Healthy Trial in New Haven (PD-0332991)
Completed
- Healthy
- PD-0332991
-
New Haven, ConnecticutPfizer Investigational Site
Nov 8, 2012